Sam Altman touts OpenAI-Microsoft alliance

Sam Altman touts OpenAI-Microsoft alliance, says next phase will be 'better than anyone is ready for'
OpenAI CEO Sam Altman posted a picture of himself with Microsoft CEO Satya Nadella on Tuesday and suggested the two companies are getting along just fine.
OpenAI's Sam Altman once warned America about Trump. Now he's partnering with him
OpenAI CEO Sam Altman's decision to join President Trump's "Stargate" AI initiative marks a stark reversal for the tech CEO, who previously was a vocal critic of Trump.
OpenAI CEO Sam Altman responds to DeepSeek hype
After the Chinese startup DeepSeek surprised everyone with its AI reasoning model, OpenAI's CEO responded to that hype.
Sam Altman says OpenAI will speed up new releases in response to 'invigorating' competition from DeepSeek
Sam Altman hailed the Chinese firm's low-cost AI model as "impressive" and said OpenAI would accelerate the release of "better models" in response.
OpenAI’s Sam Altman calls DeepSeek model ‘impressive’
OpenAI CEO and co-founder Sam Altman called Chinese artificial intelligence startup DeepSeek “impressive,” while shrugging off concerns the startup could threaten OpenAI’s
Sam Altman Praises DeepSeek R1 and Promises More From OpenAI
OpenAI Chief Executive Officer Sam Altman welcomed the debut of DeepSeek’s R1 model in a post on X late on Monday.
OpenAI CEO Sam Altman on DeepSeek R1: “an impressive model.”
Image: Now that a Chinese startup has captured a lot of the AI buzz, what happens next? The ChatGPT boss says of his company, “we will obviously deliver much better models and also it’s legit invigorating to have a new competitor,
OpenAI CEO alludes to 'next phase' of Microsoft partnership
OpenAI CEO Sam Altman said the next phase of his company's partnership with Microsoft (NASDAQ:MSFT) will surpass expectations. "(The) next phase of the msft x oai partnership is gonna be much better than anyone is ready for!
OpenAI and Microsoft gear up for next phase in partnership, Sam Altman says
In a recent development, the CEO of OpenAI, Sam Altman, has hinted at an exciting upcoming phase of partnership with Microsoft (NASDAQ:MSFT). This news came a day after the tech world was stirred by the advancements made by Chinese AI startup,
Observer5h
Sam Altman’s $5.4B Nuclear Fusion Startup Helion Baffles Science Community
Helion’s nuclear fusion promises have garnered the attention of Silicon Valley—and raised concerns amongst scientists wary of ...
Sam Altman’s Rude ‘Hopeless To Compete With Us’ Remark For India Resurfaces; Internet Says ‘Open Foot Insert Mouth’
Reactions poured in, with netizens calling Sam Altman’s remark as “ famous last words .” “ Open foot insert mouth ,” quipped ...
'Totally hopeless to compete with us': Sam Altman's old video resurfaces and goes viral amid Deepseek's rise
OpenAI founder Sam Altman is facing criticism online after an old video of him resurfaced, in which he dismissed the idea of ...
Sam Altman’s old remark on AI scene in India goes viral amid rise of China’s DeepSeek
Amid the rise of China's cheap AI model DeepSeek, Sam Altman is facing backlash for his old remark about AI startups under ...
'Better Than Before': OpenAI's Sam Altman Ups The Ante In AI War After DeepSeek Frenzy, Shares A Post Microsoft's Satya Nadella
In his latest post X, Sam Altman shared a symbolically important post. Altman shared a post, which carried a photograph of ...
You can try, but not possible to build AI with $10M: Sam Altman’s old video goes viral after DeepSeek does it with $5M
Chinese AI startup DeepSeek has taken the tech world by storm with its cost-effective, high-performance chatbot, which was developed for under $6 million—far less than the billions spent by US tech ...
Sam Altman's latest pitch to cozy up with the US government: ChatGPT Gov
Sam Altman's OpenAI launched ChatGPT Gov on Tuesday, which the company said government agencies could use to input sensitive ...
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...